AXL inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
Details for Australian Patent Application No. 2010204578 (hide)
International Classifications
Event Publications
28 July 2011 PCT application entered the National Phase
PCT publication WO2010/083465 Priority application(s): WO2010/083465
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010204583-Methods of determining patient response by measurement of Her-3
2010204576-Methods of determining patient response by measurement of HER-2 expression
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser